Saint Luke's University Health Network — Bethlehem, Pennsylvania

Saint Luke's University Health Network is a clinical research site located in Bethlehem, Pennsylvania, United States.

Crixeo Health Trust Score: 55/100 (POOR). This profile has not yet been claimed by the site owner.

Saint Luke's University Health Network has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Renal Cell Carcinoma, Ventricular Arrhythmia, Tachycardia.

Sponsors: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA, Medtronic.

Sponsor Feasibility Report

Trust Score: 55/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Luke's University Health Network?

Saint Luke's University Health Network has a Crixeo Trust Score of 55/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Luke's University Health Network conducted?

Saint Luke's University Health Network has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Renal Cell Carcinoma, Ventricular Arrhythmia, Tachycardia.

Is Saint Luke's University Health Network accredited by Crixeo Health?

Saint Luke's University Health Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Luke's University Health Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.